Clinigen to acquire Quantum Pharma for £150.3m

08:16 13/09/2017 - Clinigen Group has agreed a £150.3m cash and shares deal for Quantum Pharma.

Clinigen said Quantum's unlicensed to licensed capabilities would add significantly to the group's existing UL2L activities and would fast track its global UL2L strategy.

Under the terms of the recommended acquisition, each Quantum shareholder would receive 37 pence in cash and 0.0405 new Clinigen shares.

Clinigen said the acquisition valued each Quantum share at 82 pence, and Quantum's fully diluted share capital at approximately £150.3m, based on last night's closing price of 1,111 pence per Clinigen share.

Clinigen chief executive Shaun Chilton said: "The earnings enhancing acquisition of Quantum is an excellent operational and geographical, as well as cultural, fit with Clinigen.

"Quantum's UL2L capabilities will provide a bridge between our unlicensed and commercial businesses, mirroring our business in the AAA region. Quantum's expertise in this area will enable us to boost our global UL2L ambitions.

"Quantum also provides a European presence whilst our international footprint can immediately provide the global reach for Quantum's generic licensed products.

"With the addition of Quantum, we will be in a stronger position to drive our global expansion in the unlicensed and commercial medicine markets."

At 8:16am:
(LON:CLIN) Clinigen Group share price was -49.5p at 1061.5p
(LON:QP.) Quantum Pharma Plc share price was +10.63p at 77p

Story provided by



What the Papers Say

telegraph financial times daily mail daily express independent times
21:21 Daily briefing: NK accuses Trump; Puerto...
21:18 China takes WhatsApp messaging service...
21:15 Venezuela accuses Donald Trump of acting...
source: The Telegraph
21:00 Children leaving school fatter than ever...
source: The Telegraph
20:48 Dozens of British fighters on the loose in...
source: The Telegraph
20:43 5x5 bulletin for Monday 25 September:...
source: The Telegraph
20:27 UK wealth consultancy Alpha gears up for...
20:17 Eminem royalties shares to be sold in IPO
20:16 HBOS compensation chief criticised by Noel...
source: The Guardian
20:15 UK chip maker Imagination bought for...
source: The Guardian
[more ...]